Takeda’s dengue vaccine candidate provides continued protection against dengue fever through 4.5… EP News Bureau Jun 11, 2022 In long-term exploratory analysis, TAK-003 prevented 84 per cent of hospitalisations and 61 per cent of symptomatic dengue illness…
